Skip to main content
Signal8

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

$OCULPress releaseJun 5, 2026, 7:00 AM ETRead the release

Ocular Therapeutix granted inducement equity awards to seven newly hired non-executive employees. The grants consist of 51,775 stock options and 16,950 restricted stock units, totaling 68,725 shares.

Key figures

New hires
7
Rsu granted
16950
Exercise price
8.93
Stock options granted
51775

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.